CCCC is trading 8.1% up today at $4.46, extending its strong recent uptrend despite a lack of fresh company-specific news.

  • No new press releases, FDA decisions, M&A activity, or major analyst rating changes have been reported for June 23, 2026.
  • The move comes as broader indices trade lower, suggesting the advance is driven by speculative buying and continued momentum rather than a new fundamental trigger.